Tiansheng Pharmaceutical Group Co Ltd Working Capital to Net Assets Ratio

Latest as of September 2025: 17.4%

Tiansheng Pharmaceutical Group Co Ltd working capital to net assets ratio. Tiansheng Pharmaceutical Group Co Ltd (002872) has a Working Capital to Net Assets ratio of 17.4% as of September 2025. Working capital of CN¥343.09 Million (current assets of CN¥681.28 Million minus current liabilities of CN¥338.19 Million) is measured against net assets of CN¥1.97 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Tiansheng Pharmaceutical Group Co Ltd to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

17.4%
Working Capital / Net Assets

Working Capital

CN¥343.09 Million
CNY

Current Assets

CN¥681.28 Million
CNY

Current Liabilities

CN¥338.19 Million
CNY

Working Capital to Net Assets Ratio of Tiansheng Pharmaceutical Group Co Ltd (2012–2024)

Working capital to net assets ratio of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. This chart shows how Tiansheng Pharmaceutical Group Co Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 17.4%, reflecting working capital of CN¥343.09 Million against net assets of CN¥1.97 Billion CNY. See Tiansheng Pharmaceutical Group Co Ltd (002872) liquidity interval to measure how many days the company can operate on defensive assets alone.

Tiansheng Pharmaceutical Group Co Ltd Working Capital to Net Assets Ratio by Year (2012–2024)

Tiansheng Pharmaceutical Group Co Ltd working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Tiansheng Pharmaceutical Group Co Ltd (002872) total assets.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2024 17.0% CN¥343.12 Million CN¥2.01 Billion CN¥702.44 Million CN¥359.31 Million ▲ +5.7 pp
2023 11.3% CN¥236.49 Million CN¥2.10 Billion CN¥691.04 Million CN¥454.55 Million ▼ -0.6 pp
2022 11.9% CN¥260.69 Million CN¥2.19 Billion CN¥816.08 Million CN¥555.39 Million ▼ -7.7 pp
2021 19.6% CN¥447.65 Million CN¥2.28 Billion CN¥920.21 Million CN¥472.55 Million ▲ +2.8 pp
2020 16.8% CN¥401.27 Million CN¥2.39 Billion CN¥1.31 Billion CN¥909.66 Million ▲ +1.8 pp
2019 15.0% CN¥443.62 Million CN¥2.95 Billion CN¥1.64 Billion CN¥1.20 Billion ▼ -5.1 pp
2018 20.1% CN¥640.40 Million CN¥3.18 Billion CN¥1.88 Billion CN¥1.24 Billion ▼ -0.4 pp
2017 20.5% CN¥654.59 Million CN¥3.19 Billion CN¥2.14 Billion CN¥1.48 Billion ▲ +12.8 pp
2016 7.7% CN¥143.60 Million CN¥1.86 Billion CN¥1.41 Billion CN¥1.27 Billion ▼ -5.1 pp
2015 12.8% CN¥209.19 Million CN¥1.63 Billion CN¥1.26 Billion CN¥1.05 Billion ▼ -5.6 pp
2014 18.5% CN¥264.50 Million CN¥1.43 Billion CN¥1.11 Billion CN¥850.02 Million ▼ -7.7 pp
2013 26.1% CN¥281.70 Million CN¥1.08 Billion CN¥1.11 Billion CN¥824.35 Million ▲ +13.6 pp
2012 12.6% CN¥119.71 Million CN¥951.66 Million CN¥739.90 Million CN¥620.19 Million —
pp = percentage points